
RET gene fusions are established oncogenic drivers in 1% of non-small cell lung cancer (NSCLC). Accurate detection of advanced patients with RET fusions is essential to ensure optimal therapy choice. We investigated performance of fluorescence in situ hybridization (FISH) as diagnostic test for detecting functional RET fusions.
Like
Save
Share